期刊文献+

酶联免疫吸附试验检测HCV NS3-4A蛋白酶活性 被引量:5

Detection of Proteolytic Activity of Hepatitis C Virus NS3-4A Protease Using Enzymelinked Immunosorbent Assay
下载PDF
导出
摘要 目的 建立一种检测丙型肝炎病毒 (HCV) NS3- 4A丝氨酸蛋白酶的酶联免疫吸附试验 (EL ISA)方法 ,用于筛选 HCV蛋白酶抑制剂。方法 将质粒 p MAL- c2 / NS3- 4A转化到大肠杆菌 K1 2 TB1 中 ,经 IPTG诱导表达 ,亲和层析柱纯化后得到麦芽糖结合的 NS3/ NS3- 4A融合蛋白 ,用 Western blot分析其免疫学活性 ,并以酶联免疫吸附试验检测其生物学活性。结果  SDS- PAGE电泳分析并用考马斯亮蓝染色 ,显示相对分子质量 112 0 0 0和116 0 0 0处有麦芽糖结合的 NS3及 NS3- 4A融合蛋白带出现 ;Western blot分析表明 ,表达的产物可与抗 NS3蛋白的单克隆抗体发生阳性反应。EL ISA证实 HCV NS3- 4A蛋白酶能使特异底物裂解。正交实验获得 EL ISA的最佳实验条件 ,其 P/ N值为 3.6 3,批内和批间变异系数 (CV)分别为 4.16 %和 7.5 2 %。此方法测定 1,4萘醌对 HCV蛋白酶活性 5 0 %抑制浓度 (IC5 0 )为 8.36 μm ol/ L。结论 建立的 EL ISA方法 ,用于测定 HCV蛋白酶活性 ,具有简便、快速、重复性好等特点 ,为以 HCV NS3- 4A蛋白酶为靶酶的抑制剂筛选及抗 HCV药物的研究奠定了基础。 To establish an ELISA method for detecting proteolytic activity of HCV serine protease for screening inhibitors against HCV.Methods HCV recombinant plasmid pMAL-c2/NS3-4A was transformed into the E.coli strain K 12TB 1.Maltose-binding-protein(MBP)-NS3/NS3-4A fusion protein expression were induced by adding isopropyl-β-D-thiogalacto-pyranoside(IPTG)and purified by affinity chromatography.The immunological activities of the fusion protein were analyzed by Western blot.A peptide substrate was used to analyze the biological activity of the fusion protein.The hydrolyzed product was treated with sodium iodacetate and labeled with digoxigenin,then adding immunological anti-digoxigenin-alkaline phosphatase conjugate to detect the protease activity by colorimeteric reaction.Results The purified MBP-NS3 and MBP-NS3-4A proteases were identified as 112 000 u and 116 000 u protein by Western blot.HCV NS3/NS3-4A protease showed substrate cleavage activities by ELISA.Coefficients of variation(CV)of ELISA in a lot and among the lots were 4.16% and 7.52% respectively,the P/N was 3.63 under the best experimental conditions determined by L 9(3 4)factorial design.The method confirmed that 8.36 μmol/L 1,4-naphthoquinone had 50% inhibitive activity on HCV serine protease.Conclusions We have established a simple and rapid ELISA method with stable repeatability for detecting proteolytic activities of HCV NS3-4A protease,which might be used for screening and studying of specific inhibitors of HCV serine protease NS3-4A.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2000年第3期300-302,共3页 Acta Academiae Medicinae Sinicae
基金 国家自然科学青年基金!(3970 0 180 )
关键词 丙型肝炎病毒 ELISA NS3/NS3-4A 融合蛋白酶 hepatitis C virus enzymelinked immunosorbent assay MBP-NS3 and MBP-NS3-4A fusion protease
  • 相关文献

参考文献1

  • 1金冬雁(译),分子克隆实验指南(第2版),1992年,255-262,880-898页

同被引文献52

  • 1Wasley A, Alter MJ .Epidemiology of hepatitis C geographic differences and temporal trends [J] . Semin Liver Dis, 2000,20(1) : 1.
  • 2Hoofnagle JH,Hepatitis C.The clinical spectrum of disease[J ]. Hepatology, 1997,26(3 Suppl 1) : 15
  • 3Lindsay KL,Trepo C, Heintges T, et al .A randomized, double blind trial comparing pegylated interferon al- fa- 2b to interferon alfa- 2b as initial treatment for chronic hepatitis C[J ] .Hepatology ,2001,34(2) :395.
  • 4Cozzolongo R, Cuppone R, Manghisi OG. The treatment of chronic hepatitis C not responding to interfer- on [J ].Curr Pharm Des ,2002,8(11) :967.
  • 5Zilly M, Lingenauber C,Desch S, et al .Triple antiviral therapy for chronic hepatitis C with interferon - alpha,ribavirin and amantadine in nonresponders to interferon - alpha and ribavirin [J ] . Eur J IVied Res, 2002, 7 (4) : 149.
  • 6Piai G, Rocco P, Tartaglione MT, et al. Triple (interferon, ribavirin, amantadine) versus double (interferon, ribavirin) retherapy for interferon relapser genotype lb HCV chronic active hepatitis pa- tients [J ]. Hepatol Res, 200a, 25(4):355.
  • 7Dantzler TE, Lawitz EJ .Treatment of chronic hepatitis C in nonresponders to previous therapy[J] .Curt Gastroenterol Rep, 2003,5(1):78.
  • 8Narjes H, Yong CL, Steinmann G, et al. Tolerability and pharmaeo kinetics of BILN 2061, a novel HCV serine protease inhibitor, after oral single doses of 5 to 2 400 mg in healthy male subjects [J] . Hepatology, 2002,36(Supp14, Pt 2) :800.
  • 9Myles DC.Recent advances in the discovery of small molecule therapies for HCV[J] . Curr Opin Drug Discov Devel, 2001,4 (4) : 411.
  • 10Lou H, Choi YH, Lavoy JE, et al . Analysis of mutant NSSB proteins encoded by isolates from chimpanzees chronically infected following clonal HCV RNA inoculation [J ]. Virology, 2003,317(1) : 65.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部